News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,729 Results
Type
Article (15753)
Company Profile (262)
Press Release (280705)
Multimedia
Podcasts (127)
Webinars (13)
Section
Business (90830)
Career Advice (170)
Deals (13526)
Drug Delivery (69)
Drug Development (51102)
Employer Resources (32)
FDA (6011)
Job Trends (5224)
News (145938)
Policy (10090)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (978)
Accelerated approval (39)
ADA (34)
Adcomms (16)
Allergies (128)
Alliances (21771)
ALS (204)
Alzheimer's disease (1263)
Antibody-drug conjugate (ADC) (582)
Approvals (6441)
Artificial intelligence (491)
ASCO (224)
Autoimmune disease (410)
Automation (20)
Bankruptcy (112)
Belgium (30)
Best Places to Work (4559)
BIO (56)
Biologics (71)
BIOSECURE Act (6)
Biosimilars (161)
BioSpace Insights (81)
Biotechnology (179)
Bispecific (54)
Bladder cancer (143)
Brain cancer (73)
Breast cancer (510)
Cancer (5048)
Cardiovascular disease (375)
Career advice (174)
Career pathing (15)
CAR-T (347)
CDC (11)
CDMO (127)
Celiac Disease (6)
Cell therapy (889)
Cervical cancer (31)
Clinical research (46642)
Collaboration (1779)
Commercialization (44)
Company closure (4)
Compensation (988)
Complete response letters (73)
COVID-19 (1156)
CRISPR (131)
CRO (4)
C-suite (1057)
Cystic fibrosis (132)
Data (7642)
Denatured (27)
Depression (134)
Dermatology (131)
Diabetes (404)
Diagnostics (1562)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (360)
Drug pricing (55)
Drug shortages (4)
Duchenne muscular dystrophy (344)
Earnings (33924)
Editorial (37)
Employer branding (4)
Employer resources (30)
ESMO (311)
Events (55587)
Executive appointments (804)
Eye disease (16)
FDA (8826)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (36)
Funding (1495)
Gene editing (264)
Generative AI (50)
Gene therapy (725)
GLP-1 (638)
Government (1217)
Grass and pollen (3)
Guidances (182)
Healthcare (6833)
Hematology (144)
HIV (40)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (125)
Immunology and inflammation (291)
Immuno-oncology (123)
Indications (191)
Infectious disease (1338)
Inflammatory bowel disease (216)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (262)
Interviews (21)
IPO (7422)
IRA (13)
Job creations (871)
Job search strategy (139)
JPM (41)
Kidney cancer (13)
Kidney disease (126)
Labor market (46)
Layoffs (280)
Leadership (22)
Legal (1406)
Licensing (99)
Liver cancer (54)
Longevity (39)
Lung cancer (701)
Lung diease (21)
Lymphoma (369)
Machine learning (37)
Management (8)
Manufacturing (713)
Marketing (25)
MASH (189)
Medical affairs (4)
Medical device (2759)
Medtech (2814)
Melanoma (110)
Mergers & acquisitions (6990)
Metabolic disorders (1117)
Middle East (1)
mRNA (230)
Multiple sclerosis (162)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (433)
Neuropsychiatric disorders (105)
Neuroscience (2778)
Neurotech (2)
NextGen: Class of 2026 (2040)
Non-profit (891)
Now hiring (50)
Obesity (496)
Opinion (161)
Ovarian cancer (232)
Pain (175)
Pancreatic cancer (312)
Parkinson's disease (366)
Partnered (19)
Patents (512)
Patient advocacy (7)
Patient recruitment (682)
Patient selection (93)
Peanut (55)
People (27978)
Peptides (33)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16516)
Phase 2 (21706)
Phase 3 (13730)
Pipeline (9241)
Policy (114)
Postmarket research (853)
Preclinical (6977)
Press Release (30)
Prostate cancer (247)
Psychedelics (89)
Radioligand (3)
Radiopharmaceuticals (342)
Rare diseases (1133)
Real estate (1461)
Recruiting (12)
Regenerative medicine (24)
Regulatory (11460)
Reports (33)
Research institute (1008)
Resumes & cover letters (20)
Rett syndrome (51)
RNA editing (38)
RSV (26)
Schizophrenia (175)
Series A (295)
Series B (198)
Series C (1)
Service/supplier (1)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (131)
Sponsored (22)
Startups (2057)
State (1)
Stem cells (7)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (49)
Switzerland (15)
Tariffs (20)
The Weekly (98)
Vaccines (472)
Venture capital (120)
Weight loss (263)
Wet AMD (6)
Women's health (63)
Women in leadership (1)
Worklife (4)
Date
Last 7 days (395)
Last 30 days (2067)
Last 365 days (18396)
2026 (16919)
2025 (18094)
2024 (20467)
2023 (22412)
2022 (26810)
2021 (27802)
2020 (23355)
2019 (16222)
2018 (11735)
2017 (13743)
2016 (11838)
2015 (14349)
2014 (10393)
2013 (7483)
2012 (7535)
2011 (7614)
2010 (7429)
Location
Africa (160)
Alabama (86)
Alaska (2)
Arizona (108)
Arkansas (6)
Asia (19316)
Australia (3328)
California (10483)
Canada (2597)
China (1383)
Colorado (397)
Connecticut (395)
Delaware (364)
Europe (41379)
Florida (1380)
Georgia (289)
Hawaii (3)
Idaho (18)
Illinois (656)
India (78)
Indiana (246)
Iowa (13)
Japan (408)
Kansas (93)
Kentucky (13)
Louisiana (18)
Maine (14)
Maryland (1072)
Massachusetts (8370)
Michigan (143)
Minnesota (362)
Mississippi (4)
Missouri (41)
Montana (17)
Nebraska (6)
Nevada (71)
New Hampshire (22)
New Jersey (2357)
New Mexico (14)
New York (2545)
North Carolina (1214)
North Dakota (9)
Northern California (5449)
Ohio (254)
Oklahoma (12)
Oregon (28)
Pennsylvania (1899)
Puerto Rico (12)
Rhode Island (31)
South America (217)
South Carolina (20)
Southern California (4257)
Tennessee (72)
Texas (1505)
United States (34544)
Utah (145)
Virginia (212)
Washington D.C. (37)
Washington State (850)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
296,729 Results for "genecentric therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GeneCentric Announces Oral Presentation at ASHG 2026 Highlighting Fragmentomics-based ExpressCT™ Liquid Biopsy Technology
October 14, 2026
·
1 min read
Press Releases
GeneCentric Launches ExpressCT Rewind™ to Unlock Gene Expression Insights from Existing Liquid Biopsy DNA Sequencing
July 8, 2026
·
2 min read
Press Releases
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026
April 14, 2026
·
3 min read
Bio NC
GeneCentric Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
GeneCentric Therapeutics today announced upcoming presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Illinois from May 31st to June 4th.
May 20, 2024
·
2 min read
Bio NC
GeneCentric Therapeutics Announces Upcoming Presentations at the American Association for Cancer Research Annual Meeting 2024
GeneCentric Therapeutics today announced upcoming presentations at the American Association for Cancer Research Annual Meeting 2024 being held in San Diego, California from April 5-10.
April 1, 2024
·
2 min read
Press Releases
GeneCentric Therapeutics Launches EXpressCT Liquid Biopsy Platform
October 28, 2024
·
3 min read
Press Releases
GeneCentric Announces Series C Financing to Advance Novel Liquid Biopsy Platform for Precision Oncology
June 18, 2025
·
4 min read
Business
GeneCentric Therapeutics Appoints Brian Kelly as SVP Business Development
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Brian Kelly as Senior Vice President of Business Development.
April 12, 2023
·
2 min read
Business
GeneCentric Therapeutics Appoints Prasanth Reddy and Don Hardison to the Board of Directors as the Company Advances Its Oncology Diagnostics Pipeline
GeneCentric Therapeutics today announced the appointment of Prasanth Reddy, MD, MPH, FACP, and Don Hardison as independent directors of its Board of Directors.
November 14, 2023
·
2 min read
Bio NC
GeneCentric Therapeutics Announces Commercial Availability of PurIST℠ Test for Pancreatic Cancer
GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, announced today that its PurIST℠ test is now commercially available through Tempus for clinical use.
May 31, 2023
·
3 min read
1 of 29,673
Next